Sign in
4

Changes in Ownership

Neurogene Inc. Filed Acc 0001209191-20-019430

Options or other derivatives

  • Chief Financial Officer acquired 275,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ho Robert · Chief Financial Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-03-16 Grant or award : show line 1 in the form Restricted Stock Units +75,000 75,000 D
2020-03-16 Grant or award : show line 2 in the form Stock Option (Right to Buy) +200,000 200,000 D
Loading xslF345X03/doc4.xml…